Direct In Vivo Activation of T Cells with Nanosized Immunofilaments Inhibits Tumor Growth and Metastasis.
Saved in:
| Title: | Direct In Vivo Activation of T Cells with Nanosized Immunofilaments Inhibits Tumor Growth and Metastasis. |
|---|---|
| Authors: | Weiss L; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Institute for Chemical Immunology, 6525 GA Nijmegen, The Netherlands., Weiden J; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Institute for Chemical Immunology, 6525 GA Nijmegen, The Netherlands., Dölen Y; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Grad EM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., van Dinther EAW; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Schluck M; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Institute for Chemical Immunology, 6525 GA Nijmegen, The Netherlands., Eggermont LJ; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., van Mierlo G; Laboratory of Systems Biology and Genetics, Institute of Bioengineering, School of Life Sciences, Swiss Federal Institute of Technology (EPFL), 1015 CH Lausanne, Switzerland., Gileadi U; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, OX3 9DS Oxford, United Kingdom., Bartoló-Ibars A; Department of Immunology, Hospital Clinic, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Carrer Villarroel 170, 08036 Barcelona, Spain., Raavé R; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Geert Grooteplein-Zuid 10, 6525 HP Nijmegen, The Netherlands., Gorris MAJ; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Maassen L; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands., Verrijp K; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Valente M; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Deplancke B; Laboratory of Systems Biology and Genetics, Institute of Bioengineering, School of Life Sciences, Swiss Federal Institute of Technology (EPFL), 1015 CH Lausanne, Switzerland., Verdoes M; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Institute for Chemical Immunology, 6525 GA Nijmegen, The Netherlands., Benitez-Ribas D; Department of Immunology, Hospital Clinic, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Carrer Villarroel 170, 08036 Barcelona, Spain., Heskamp S; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Geert Grooteplein-Zuid 10, 6525 HP Nijmegen, The Netherlands., van Spriel AB; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Institute for Chemical Immunology, 6525 GA Nijmegen, The Netherlands., Figdor CG; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Institute for Chemical Immunology, 6525 GA Nijmegen, The Netherlands., Hammink R; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands. |
| Source: | ACS nano [ACS Nano] 2023 Jul 11; Vol. 17 (13), pp. 12101-12117. Date of Electronic Publication: 2023 Jun 20. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Chemical Society Country of Publication: United States NLM ID: 101313589 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1936-086X (Electronic) Linking ISSN: 19360851 NLM ISO Abbreviation: ACS Nano Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37338806 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Direct In Vivo Activation of T Cells with Nanosized Immunofilaments Inhibits Tumor Growth and Metastasis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Weiss+L%22">Weiss L</searchLink>; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Institute for Chemical Immunology, 6525 GA Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Weiden+J%22">Weiden J</searchLink>; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Institute for Chemical Immunology, 6525 GA Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Dölen+Y%22">Dölen Y</searchLink>; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Grad+EM%22">Grad EM</searchLink>; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Dinther+EAW%22">van Dinther EAW</searchLink>; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Schluck+M%22">Schluck M</searchLink>; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Institute for Chemical Immunology, 6525 GA Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Eggermont+LJ%22">Eggermont LJ</searchLink>; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Mierlo+G%22">van Mierlo G</searchLink>; Laboratory of Systems Biology and Genetics, Institute of Bioengineering, School of Life Sciences, Swiss Federal Institute of Technology (EPFL), 1015 CH Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Gileadi+U%22">Gileadi U</searchLink>; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, OX3 9DS Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Bartoló-Ibars+A%22">Bartoló-Ibars A</searchLink>; Department of Immunology, Hospital Clinic, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Carrer Villarroel 170, 08036 Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Raavé+R%22">Raavé R</searchLink>; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Geert Grooteplein-Zuid 10, 6525 HP Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Gorris+MAJ%22">Gorris MAJ</searchLink>; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Maassen+L%22">Maassen L</searchLink>; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Verrijp+K%22">Verrijp K</searchLink>; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Valente+M%22">Valente M</searchLink>; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Deplancke+B%22">Deplancke B</searchLink>; Laboratory of Systems Biology and Genetics, Institute of Bioengineering, School of Life Sciences, Swiss Federal Institute of Technology (EPFL), 1015 CH Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Verdoes+M%22">Verdoes M</searchLink>; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Institute for Chemical Immunology, 6525 GA Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Benitez-Ribas+D%22">Benitez-Ribas D</searchLink>; Department of Immunology, Hospital Clinic, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Carrer Villarroel 170, 08036 Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Heskamp+S%22">Heskamp S</searchLink>; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Geert Grooteplein-Zuid 10, 6525 HP Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Spriel+AB%22">van Spriel AB</searchLink>; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Institute for Chemical Immunology, 6525 GA Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Figdor+CG%22">Figdor CG</searchLink>; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Institute for Chemical Immunology, 6525 GA Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Hammink+R%22">Hammink R</searchLink>; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101313589%22">ACS nano</searchLink> [ACS Nano] 2023 Jul 11; Vol. 17 (13), pp. 12101-12117. <i>Date of Electronic Publication: </i>2023 Jun 20. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Chemical+Society%22">American Chemical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101313589 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1936-086X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219360851%22">19360851 </searchLink><i>NLM ISO Abbreviation: </i>ACS Nano <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37338806 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1021/acsnano.2c11884 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 12101 Titles: – TitleFull: Direct In Vivo Activation of T Cells with Nanosized Immunofilaments Inhibits Tumor Growth and Metastasis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Weiss L – PersonEntity: Name: NameFull: Weiden J – PersonEntity: Name: NameFull: Dölen Y – PersonEntity: Name: NameFull: Grad EM – PersonEntity: Name: NameFull: van Dinther EAW – PersonEntity: Name: NameFull: Schluck M – PersonEntity: Name: NameFull: Eggermont LJ – PersonEntity: Name: NameFull: van Mierlo G – PersonEntity: Name: NameFull: Gileadi U – PersonEntity: Name: NameFull: Bartoló-Ibars A – PersonEntity: Name: NameFull: Raavé R – PersonEntity: Name: NameFull: Gorris MAJ – PersonEntity: Name: NameFull: Maassen L – PersonEntity: Name: NameFull: Verrijp K – PersonEntity: Name: NameFull: Valente M – PersonEntity: Name: NameFull: Deplancke B – PersonEntity: Name: NameFull: Verdoes M – PersonEntity: Name: NameFull: Benitez-Ribas D – PersonEntity: Name: NameFull: Heskamp S – PersonEntity: Name: NameFull: van Spriel AB – PersonEntity: Name: NameFull: Figdor CG – PersonEntity: Name: NameFull: Hammink R IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 07 Text: 2023 Jul 11 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1936-086X Numbering: – Type: volume Value: 17 – Type: issue Value: 13 Titles: – TitleFull: ACS nano Type: main |
| ResultId | 1 |